|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 24 September 2003
doi: 10.1242/dev.00755
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratoire d'Embryologie cellulaire et moléculaire du CNRS et du
Collège de France, 49 bis, avenue de la Belle Gabrielle, 94736 Nogent
s/Marne cedex, France
2 Laboratório de Neurobiologia e Hematologia Celular e Molecular, BEG,
CCB, Universidade Federal de Santa Catarina, Campus Universitário,
88040-900, Florianópolis, SC, Brazil
* Author for correspondence (e-mail: fdieterlen{at}college-de-france.fr)
Accepted 25 July 2003
Placenta and yolk sac from 8- to 17-day-old (E8-E17) mouse embryos/fetuses were investigated for the presence of in vitro clonogenic progenitors. At E8-E9, the embryonic body from the umbilicus caudalwards was also analysed. Fetal liver was analysed beginning on E10. At E8, between five and nine somite pairs (sp), placenta, yolk sac and embryonic body yielded no progenitors. The first progenitors appeared at E8.5 at the stage of 15 sp in the yolk sac, 18 sp in the embryonic body, 20 sp in the placenta and only at E12 in the fetal liver (absent at E10, at E11 not determined). Progenitors with a high proliferation potential that could be replated for two months, as well as the whole range of myeloid progenitors, were found at all stages in all organs. However, the earliest of these progenitors (these yielding large, multilineage colonies) were 2-4 times more frequent in the placenta than in the yolk sac or fetal liver. In the fetal liver, late progenitors were more frequent and the cellularity increased steeply with developmental age. Thus, the fetal liver, which is a recognized site for amplification and commitment, has a very different hematopoietic developmental profile from placenta or yolk sac. Placentas were obtained from GFP transgenic embryos in which only the embryonic contribution expressed the transgene. 80% of the colonies derived from these placental cells were GFP+, and so originated from the fetal component of the placenta. These data point to the placenta as a major hematopoietic organ that is active during most of pregnancy.
Key words: Placenta, Hematopoiesis, Clonogenic progenitors, Mouse
This article has been cited by other articles:
|
|
 |
|
  E. Dzierzak and A. Medvinsky The discovery of a source of adult hematopoietic cells in the embryo Development, July 15, 2008; 135(14): 2343 - 2346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Parolini, F. Alviano, G. P. Bagnara, G. Bilic, H.-J. Buhring, M. Evangelista, S. Hennerbichler, B. Liu, M. Magatti, N. Mao, et al. Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells Stem Cells, February 1, 2008; 26(2): 300 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Martinez-Agosto, H. K.A. Mikkola, V. Hartenstein, and U. Banerjee The hematopoietic stem cell and its niche: a comparative view Genes & Dev., December 1, 2007; 21(23): 3044 - 3060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Naujokat and T. Saric Concise Review: Role and Function of the Ubiquitin-Proteasome System in Mammalian Stem and Progenitor Cells Stem Cells, October 1, 2007; 25(10): 2408 - 2418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Zeigler, D. Sugiyama, M. Chen, Y. Guo, K. M. Downs, and N. A. Speck The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential Development, November 1, 2006; 133(21): 4183 - 4192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Migliaccio and S. Philipsen Reflections on the European Union Eurythron Network Meeting "Molecular Control of Erythropoiesis," September 22-23, 2005, Istituto Superiore Di Sanita, Rome, Italy Stem Cells, November 1, 2006; 24(11): 2478 - 2482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. A. Mikkola and S. H. Orkin The journey of developing hematopoietic stem cells. Development, October 1, 2006; 133(19): 3733 - 3744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mu and S. L. Adamson Developmental changes in hemodynamics of uterine artery, utero- and umbilicoplacental, and vitelline circulations in mouse throughout gestation Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1421 - H1428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Barnes, S. Huang, A. Kaipainen, D. Sanoudou, E. J. Chen, G. S. Eichler, Y. Guo, Y. Yu, D. E. Ingber, J. B. Mulliken, et al. Evidence by molecular profiling for a placental origin of infantile hemangioma PNAS, December 27, 2005; 102(52): 19097 - 19102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Khosrotehrani and D. W. Bianchi Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse J. Cell Sci., April 15, 2005; 118(8): 1559 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K.A. Mikkola, C. Gekas, F. Dieterlen-Lievre, and S. H. Orkin Placenta Is a Niche for Hematopoietic Stem Cells. Blood (ASH Annual Meeting Abstracts), November 16, 2004; 104(11): 2671 - 2671. [Abstract]
|
|
|
|
 |
|
 C. Menier, M. Rabreau, J.-C. Challier, M. Le Discorde, E. D. Carosella, and N. Rouas-Freiss Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis Blood, November 15, 2004; 104(10): 3153 - 3160. [Abstract] [Full Text] [PDF]
|
|
